RWLK - ReWalk Robotics Ltd.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.7700
-0.0459 (-5.63%)
As of 10:12AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.8159
Open0.7580
Bid0.7700 x 4000
Ask0.7730 x 800
Day's Range0.7580 - 0.7879
52 Week Range0.7000 - 1.6000
Volume93,402
Avg. Volume784,789
Market Cap27.35M
Beta (3Y Monthly)-0.04
PE Ratio (TTM)N/A
EPS (TTM)-0.8770
Earnings DateOct 31, 2018 - Nov 5, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.50
Trade prices are not sourced from all markets
  • Simply Wall St.20 days ago

    Do You Know Who Else Invests In ReWalk Robotics Ltd (NASDAQ:RWLK)?

    A look at the shareholders of ReWalk Robotics Ltd (NASDAQ:RWLK) can tell us which group is most powerful. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, Read More...

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of RWLK earnings conference call or presentation 14-Aug-18 12:30pm GMT

    Q2 2018 Rewalk Robotics Ltd Earnings Call

  • PR Newswire2 months ago

    ReWalk Robotics (RWLK) Investigated by Block & Leviton LLP For Violations of Federal Securities Laws

    BOSTON , Aug. 28, 2018 /PRNewswire/ -- Block & Leviton LLP ( www.blockesq.com ), a securities litigation firm representing investors nationwide, is investigating whether ReWalk Robotics ("ReWalk" ...

  • GlobeNewswire2 months ago

    ReWalk Robotics to Present at the H.C. Wainwright 20th Annual Global Investment Conference on September 6th

    MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Aug. 23, 2018-- ReWalk Robotics Ltd. today announced that Larry Jasinski, Chief Executive Officer, and Ori Gon, Chief Financial Officer, will present at the ...

  • TheStreet.com2 months ago

    Rewalk Robotics CEO Reveals a Path to Profitability Amid Plunging Stock Price

    Rewalk Robotics shares are trading at roughly $1 a share - a far cry from the $25 threshold reached in September 2014 following its IPO on the Nasdaq.

  • Associated Press2 months ago

    ReWalk: 2Q Earnings Snapshot

    The Yokneam Ilit, Israel-based company said it had a loss of 18 cents per share. The maker of wearable robotic exoskeletons that help paralyzed patients walk posted revenue of $1.8 million in the period. ...

  • GlobeNewswire2 months ago

    ReWalk Robotics Reports Second Quarter 2018 Financial Results

    —Total revenue of $1.8 million during the second quarter of 2018—. —VA updates national coverage policy which expands access to ReWalk exoskeletons—. YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Aug. 14, ...

  • ACCESSWIRE2 months ago

    ReWalk Robotics Ltd. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 14, 2018 / ReWalk Robotics Ltd. (NASDAQ: RWLK ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 14, 2018 at 8:30 AM Eastern Time. ...

  • GlobeNewswire2 months ago

    ReWalk Robotics to Report Second Quarter 2018 Financial Results on August 14, 2018

    MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Aug. 10, 2018-- ReWalk Robotics Ltd. today announced that the Company will release its second quarter 2018 financial results on Tuesday, August 14, 2018, before ...

  • First U.S. ReWalker to Receive 2nd Exoskeleton System through U.S. Department of Veterans Affairs National Policy
    PR Newswire3 months ago

    First U.S. ReWalker to Receive 2nd Exoskeleton System through U.S. Department of Veterans Affairs National Policy

    MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, July 30, 2018 /PRNewswire/ -- ReWalk Robotics, Ltd. (RWLK) ("ReWalk" or the "Company") announced today that Retired Marine Captain Derek Herrera, the first American to obtain a ReWalk Personal system after FDA clearance in 2014, has gained approval to  receive a new exoskeleton system courtesy of the U.S. Department of Veterans Affairs procurement program. The VA's policy to provide exoskeletons to paralyzed Veterans was issued in 2015 and benefits Veterans with either service or non-service connected spinal cord injuries. A June 2018 revision to the policy expanded access to training locations across the VA spinal cord injury care network as well as to private rehabilitation centers through the VA's Veterans Choice Program.

  • ACCESSWIRE3 months ago

    Today’s Research Reports on Stocks to Watch: ReWalk Robotics and iRobot

    NEW YORK, NY / ACCESSWIRE / July 23, 2018 / Shares of ReWalk soared over 70% on Friday after the company announced that the U.S. Department of Veterans Affairs has issued a revision to its national policy on exoskeleton medical device training and procurement for qualifying Veterans with spinal cord injury (SCI). Shares of iRobot dropped about 5%. ReWalk Robotics Ltd. shares closed up almost 74% on Friday with a little over 21 million shares traded.

  • Why Rewalk Robotics (RWLK) Stock Is Skyrocketing Today
    InvestorPlace3 months ago

    Why Rewalk Robotics (RWLK) Stock Is Skyrocketing Today

    The Israel-based company said that the aforementioned agency issued a revision to the company’s national policy regarding its exoskeleton medical device training and procurement for qualifying Veterans with spinal cord injury (SCI). Plus, the announcement also means that more veterans will have access to Rewalk Robotics training program locations across the VA network, as well as expanded access to private rehabilitation centers through the company’s Veterans Choice Program.

  • Why Is ReWalk Robotics Stock Rising Today?
    Market Realist3 months ago

    Why Is ReWalk Robotics Stock Rising Today?

    On July 20, exoskeleton developer ReWalk Robotics (RWLK) announced a revised national policy from the United States Department of Veterans Affairs. With the company working closely with United States Department of Veterans Affairs, the country’s largest network of care for SCI patients, the news of the updated policy boosted ReWalk Robotics stock by ~73.6% to reach $1.25 on July 20.

  • U.S. Department of Veterans Affairs Expands Access to ReWalk Exoskeletons for Paralyzed Veterans with Revised National Policy
    PR Newswire3 months ago

    U.S. Department of Veterans Affairs Expands Access to ReWalk Exoskeletons for Paralyzed Veterans with Revised National Policy

    MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, July 20, 2018 /PRNewswire/ -- ReWalk Robotics, Ltd. (RWLK) ("ReWalk" or the "Company") announced that the U.S. Department of Veterans Affairs has issued a revision to its national policy on exoskeleton medical device training and procurement for qualifying Veterans with spinal cord injury (SCI). The updated policy includes further guidance on the evaluation process and expands access to training program locations among the VA network and private rehabilitation centers through the VA's Veterans Choice Program.

  • GlobeNewswire3 months ago

    ReWalk Completes Amendment with Wyss Institute at Harvard University to Extend Agreement to June 2022

    ReWalk Robotics, Ltd. (RWLK) ("ReWalk" or the "Company") announced today that the Company has completed an amendment to the working agreement with the Wyss Institute at Harvard University (Wyss). This extension allows ReWalk to complete additional research programs with Wyss as well as to pace the efforts more efficiently. The total investment by ReWalk remains unchanged and will be spread out over an extra year, which is expected to benefit the Company’s cash flow.

  • ReWalk Announces Progress in Clinical Study of ReStore Powered Exo-Suit
    PR Newswire4 months ago

    ReWalk Announces Progress in Clinical Study of ReStore Powered Exo-Suit

    MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, June 28, 2018 /PRNewswire/ -- ReWalk Robotics, Ltd. (RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, announced today that the Institutional Review Boards of five leading U.S. research institutions have approved ReWalk's clinical study of the ReStore soft exo-suit device. "We expect that the expansion of our clinical study to these renowned research organizations will bring the ReStore exo-suit closer to CE and FDA clearance,'' said ReWalk CEO Larry Jasinski. ''The ReStore will offer an immediate and cost-effective solution for the more than three million stroke patients in the U.S. with lower limb disabilities.

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of RWLK earnings conference call or presentation 10-May-18 8:30pm GMT

    Q1 2018 Rewalk Robotics Ltd Earnings Call

  • Associated Press5 months ago

    ReWalk: 1Q Earnings Snapshot

    The Yokneam Ilit, Israel-based company said it had a loss of 21 cents per share. Losses, adjusted for non-recurring costs, were 18 cents per share. The maker of wearable robotic exoskeletons that help ...

  • VA now covering ReWalk exoskeleton for paralyzed veterans
    Fox Business Videos2 months ago

    VA now covering ReWalk exoskeleton for paralyzed veterans

    ReWalk Robotics CEO Larry Jasinski on the company's device that helps people walk after being paralyzed.

  • New exoskeleton designed to help stroke survivors walk
    Fox Business Videos6 months ago

    New exoskeleton designed to help stroke survivors walk

    ReWalk Robotics CEO Larry Jasinski and Restore Exo-Suit Product Manager Kathleen O'Donnell on a new exoskeleton developed to help stroke survivors walk.